Literature DB >> 6607214

Anamnestic responses induced by antigen persisting on follicular dendritic cells from cyclophosphamide-treated mice.

R P Phipps, T E Mandel, C T Schnizlein, J G Tew.   

Abstract

In contrast to most mouse lymph node cells, follicular dendritic cells (FDCs) resist cyclophosphamide (Cy; 300 mg/kg)-mediated destruction in vivo. In this study we sought to determine if antigen-bearing FDCs from Cy-treated animals maintained biological activity. We were especially interested in whether FDCs from Cy-treated animals could stimulate an antibody response when combined with primed spleen cells and whether the FDCs needed to be intact and viable for stimulation to occur. The effect of Cy treatment on lymph node histology, number of T cells and B cells, and the 'spontaneous antibody response' was determined. Cy treatment resulted in a massive depletion of the lymph node cortex and a loss of follicles and germinal centres. Over 90% of B cells in the lymph node were eliminated. The paracortex was more resistant although nearly 80% of T cells were eliminated. Cy treatment also eliminated the 'spontaneous antibody response' as established by in vitro culture or after adoptive transfer. The addition of primed spleen cells to antigen-bearing FDCs including sonicated non-viable FDCs from Cy-treated animals resulted in an anamnestic antibody response. Memory lymphocytes, injected into the hind foot pads of Cy-treated animals, migrated to the follicular area of popliteal lymph nodes and cells from these reconstituted nodes spontaneously responded upon subsequent adoptive transfer. It was concluded that antigen retained on Cy-treated FDCs maintains its immunogenicity and is capable of inducing a 'spontaneous antibody response' or an anamnestic response. Furthermore antigen on FDCs or on fragments of FDCs from one animal can interact with memory cells from another animal to induce a productive antibody response. Lymph nodes enriched for FDCs by Cy treatment should be a good source of FDCs for isolation and further study of the nature of this interaction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6607214      PMCID: PMC1454438     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  Suppressor cell regulation of the spontaneously induced in vitro secondary antibody response.

Authors:  L H Elliott; T L Roszman
Journal:  Cell Immunol       Date:  1978-09-15       Impact factor: 4.868

2.  The separation of different cell classes from lymphoid organs. IX. A simple and rapid method for removal of damaged cells from lymphoid cell suspensions.

Authors:  H von Boehmer; K Shortman
Journal:  J Immunol Methods       Date:  1973-04       Impact factor: 2.303

3.  The spontaneous induction of anamnestic antibody synthesis in lymph node cell cultures many months after primary immunization.

Authors:  J G Tew; C H Self; W W Harold; A B Stavitsky
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

Review 4.  The follicular dendritic cell: long term antigen retention during immunity.

Authors:  T E Mandel; R P Phipps; A Abbot; J G Tew
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

5.  Retention of intact HSA for prolonged periods in the popliteal lymph nodes of specifically immunized mice.

Authors:  J G Tew; T E Mandel; A W Burgess
Journal:  Cell Immunol       Date:  1979-06       Impact factor: 4.868

6.  The maintenance and regulation of serum antibody levels: evidence indicating a role for antigen retained in lymphoid follicles.

Authors:  J G Tew; T Mandel
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

Review 7.  The maintenance and regulation of the humoral immune response: persisting antigen and the role of follicular antigen-binding dendritic cells as accessory cells.

Authors:  J G Tew; R P Phipps; T E Mandel
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

8.  Regulation of the IgE antibody response in mice. I. Long-term production of IgE Anti-ovalbumin antibody in irradiated recipients.

Authors:  S H Peeters; B G Carter
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

9.  In vitro studies linking induction of spontaneous antibody synthesis to an accessory cell with persisting antigen on its surface.

Authors:  J G Tew; A B Stavitsky
Journal:  Cell Immunol       Date:  1974-10       Impact factor: 4.868

10.  The differentiation of murine thymocytes in vivo and in vitro.

Authors:  T E Mandel; M M Kennedy
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

View more
  7 in total

1.  Iccosomes and the secondary antibody response.

Authors:  G F Burton; M H Kosco; A K Szakal; J G Tew
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

2.  Cyclophosphamide induces dynamic alterations in the host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cells.

Authors:  Mohamed L Salem; Amir A Al-Khami; Sabry A El-Naggar; C Marcela Díaz-Montero; Yian Chen; David J Cole
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

Review 3.  Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination.

Authors:  Mohamed Labib Salem; David J Cole
Journal:  Cancer Immunol Immunother       Date:  2009-11-18       Impact factor: 6.968

4.  Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination antitumor responses in vivo when stimulated with the TLR3 agonist poly(I:C).

Authors:  Mohamed L Salem; C Marcela Díaz-Montero; Amir A Al-Khami; Sabry A El-Naggar; Osama Naga; Alberto J Montero; Ahmed Khafagy; David J Cole
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

5.  Hybrid resistance modulates the inflammatory process induced by lymphocytic choriomeningitis virus-immune T cells.

Authors:  P C Doherty; J E Allan
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

6.  Kinetics of rebounding of lymphoid and myeloid cells in mouse peripheral blood, spleen and bone marrow after treatment with cyclophosphamide.

Authors:  Mohamed L Salem; Amir A Al-Khami; Sabry A El-Nagaar; Abdel-Aziz A Zidan; Ismail M Al-Sharkawi; C Marcela Díaz-Montero; David J Cole
Journal:  Cell Immunol       Date:  2012-04-11       Impact factor: 4.868

7.  Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo.

Authors:  Mohamed L Salem; Sabry A El-Naggar; David J Cole
Journal:  Cell Immunol       Date:  2009-12-05       Impact factor: 4.868

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.